Effect of changing the age criteria for blood donors

M Goldman1, E Fournier, K Cameron-Choi

  • 1Canadian Blood Services, Ottawa, Ontario, Canada. mindy.goldman@blood.ca

Vox Sanguinis
|April 26, 2007
PubMed

Insights

Removing the upper age limit for blood donation in Canada allows healthy seniors to continue donating. This study found that older donors aged 71 and above can donate blood safely without extra medical steps.

Area of Science:

  • Transfusion Medicine
  • Geriatric Medicine
  • Public Health

Background:

  • Upper age limits for allogeneic blood donation differ globally.
  • Canada removed its upper age limit for blood donation from December 2004 to January 2006.

Purpose of the Study:

  • To assess the safety and impact of removing the upper age limit for blood donation in Canada.
  • To evaluate donor reactions and deferral rates in older donors.

Main Methods:

  • Regular donors aged 71+ were permitted to continue donation with an annual medical assessment.
  • Donors aged 70-74 received information encouraging continued donation.
  • Adverse reaction and deferral rates were compared between age groups.

Main Results:

  • 98% of completed medical inquiries resulted in physician approval for continued donation.
  • 93% of eligible older donors successfully donated.
  • The rate of moderate/severe donor reactions in donors aged 71+ was not statistically different from the general donor population.

Conclusions:

  • Regular blood donors can safely donate past age 71.
  • Mandatory external medical inquiries may not be necessary for older donors.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...